Optimized Peptide-MHC Multimer Protocols for Detection and Isolation of Autoimmune T-Cells

Area of Science:

• Immunology
• Cell Biology
• Biotechnology

Background:

• Peptide-MHC (pMHC) multimers are standard for T-cell detection but miss low-affinity T-cells.
• Self-reactive T-cells, crucial in autoimmunity and cancer, often possess low-affinity T-cell receptors (TCRs).
• Immune tolerance mechanisms eliminate high-affinity self-reactive T-cells, enriching low-affinity populations.

Purpose of the Study:

• To develop and validate an optimized pMHC multimer staining technique for detecting low-affinity, self-reactive T-cells.
• To compare the efficacy of the optimized protocol against standard pMHC staining methods.
• To enable improved isolation of functional autoimmune T-cells from clinical samples.

Main Methods:

• Utilized protein kinase inhibitors (PKI) to prevent TCR triggering and internalization.
• Employed anti-fluorochrome antibodies to minimize reagent dissociation during washing.
• Tested the optimized protocol on T-cells from type 1 diabetes and ankylosing spondylitis patients using specific pMHC multimers.
• Compared pMHC dextramers and tetramers; assessed staining with anti-fluorochrome antibody-conjugated magnetic beads.

Main Results:

• The optimized protocol detected an average of 40.5-fold more cells compared to standard methods.
• Higher-order pMHC dextramers outperformed pMHC tetramers in cell recovery.
• T-cell clones identified via optimized staining were undetectable by standard pMHC tetramer staining.
• Optimized staining enabled rapid ex vivo isolation of previously undetectable autoimmune T-cells.

Conclusions:

• Standard pMHC tetramer staining is inadequate for recovering most self-reactive T-cells from clinical samples.
• The developed optimized protocols significantly enhance the detection and isolation of low-affinity, functional T-cells.
• This improved methodology is vital for advancing research and diagnostics in autoimmune diseases and cancer immunotherapy.